Emily Kim

1.0k total citations
51 papers, 587 citations indexed

About

Emily Kim is a scholar working on Oncology, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Emily Kim has authored 51 papers receiving a total of 587 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 8 papers in Epidemiology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Emily Kim's work include Cancer, Hypoxia, and Metabolism (5 papers), Polyomavirus and related diseases (4 papers) and Cutaneous Melanoma Detection and Management (4 papers). Emily Kim is often cited by papers focused on Cancer, Hypoxia, and Metabolism (5 papers), Polyomavirus and related diseases (4 papers) and Cutaneous Melanoma Detection and Management (4 papers). Emily Kim collaborates with scholars based in United States, South Korea and Germany. Emily Kim's co-authors include Gerd Walz, Thomas Benzing, W Grüning, Sergei Y. Sokol, Thierry Arnould, Lorenz Sellin, Iain A. Drummond, Stefan Zschiedrich, Diane C Lim and Nathan Kuppermann and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Emily Kim

38 papers receiving 573 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Emily Kim United States	13	264	220	104	76	70	51	587
Monica H. Wojcik United States	15	242 0.9×	406 1.8×	99 1.0×	42 0.6×	44 0.6×	69	737
Tracy L. Trotter United States	13	137 0.5×	400 1.8×	142 1.4×	73 1.0×	39 0.6×	19	821
Jose Bernardo Quintos United States	16	430 1.6×	357 1.6×	45 0.4×	104 1.4×	25 0.4×	59	1.2k
Daniel Weng United States	16	264 1.0×	46 0.2×	88 0.8×	156 2.1×	51 0.7×	33	707
Nakao Konishi Japan	12	165 0.6×	98 0.4×	79 0.8×	77 1.0×	16 0.2×	26	618
John Oyston Canada	7	274 1.0×	194 0.9×	57 0.5×	52 0.7×	43 0.6×	14	714
Marina Pontillo Italy	12	145 0.5×	64 0.3×	237 2.3×	34 0.4×	28 0.4×	35	915
Hans‐Georg Zmierczak Belgium	18	305 1.2×	132 0.6×	36 0.3×	124 1.6×	64 0.9×	42	936
Shelley de Kock United Kingdom	9	323 1.2×	92 0.4×	55 0.5×	63 0.8×	34 0.5×	14	711
Makoto Anzo Japan	18	259 1.0×	147 0.7×	60 0.6×	103 1.4×	8 0.1×	35	794

Countries citing papers authored by Emily Kim

Since Specialization

Citations

This map shows the geographic impact of Emily Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily Kim more than expected).

Fields of papers citing papers by Emily Kim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily Kim. The network helps show where Emily Kim may publish in the future.

Co-authorship network of co-authors of Emily Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Emily Kim. A scholar is included among the top collaborators of Emily Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily Kim. Emily Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fanaroff, Alexander C., Emily Kim, Charles Rareshide, et al.. (2024). A randomized controlled trial of gamification to increase physical activity among black and Hispanic breast and prostate cancer survivors: Rationale and design of the ALLSTAR clinical trial. American Heart Journal. 280. 42–51. 1 indexed citations

Kim, Emily, Emily S. Ruiz, Sophia Z. Shalhout, et al.. (2024). Neoadjuvant-Intent Immunotherapy in Advanced, Resectable Cutaneous Squamous Cell Carcinoma. JAMA Otolaryngology–Head & Neck Surgery. 150(5). 414–414. 10 indexed citations

Kim, Emily, et al.. (2024). Male Breast Cancer With Dual BRCA2 and BRIP1 Deleterious Gene Mutations. Ochsner Journal. 24(2). 157–161.

Knott, Eric P., Emily Kim, Yujie Wang, et al.. (2024). Orthotopic Models Using New, Murine Lung Adenocarcinoma Cell Lines Simulate Human Non-Small Cell Lung Cancer Treated with Immunotherapy. Cells. 13(13). 1120–1120. 3 indexed citations

Kim, Emily, et al.. (2024). Patterns of initial distant metastases in 151 patients undergoing surveillance for treated Merkel cell carcinoma. Journal of the European Academy of Dermatology and Venereology. 38(6). 1202–1212. 2 indexed citations

Kim, Emily, et al.. (2024). Comparison of Efficacy of Micropulse Laser Settings for Glaucoma Management. Journal of Clinical Medicine. 13(19). 5753–5753.

Kim, Emily, et al.. (2023). Everolimus-induced Symmetrical Drug-related Intertriginous and Flexural Exanthema. Acta Dermato Venereologica. 103. adv12197–adv12197.

Kim, Emily, et al.. (2023). Systematic review of benefits and practical challenges for application of Mohs surgery for oral tumors. Archives of Dermatological Research. 315(9). 2479–2484.

Miller, David M., Howard L. Kaufman, Kevin S. Emerick, et al.. (2023). Perioperative Immunotherapy for High-Risk Resectable Melanoma - A New Standard?. 1(1). 1 indexed citations

10.

Kim, Emily, Sophia Z. Shalhout, Howard L. Kaufman, et al.. (2023). Tumor-Infiltrating Lymphocyte Therapy for Advanced Melanoma: Ready for Prime Time?. 1(1). 2 indexed citations

11.

Granger, Emily, Emily Kim, Ann W. Silk, et al.. (2023). Definitive radiation therapy for inoperable stage III/IV cutaneous squamous cell carcinoma: A single-institution retrospective cohort study. Journal of the American Academy of Dermatology. 90(1). 187–189.

12.

Miller, David M., Howard L. Kaufman, Kevin S. Emerick, et al.. (2022). Neoadjuvant Nivo/Rela for Resectable Melanoma. 1(1). 2 indexed citations

13.

Lee, Kyungmin, Jamie DeCoster, Won‐Il Lee, et al.. (2022). Influence of oxidizing and reducing pretreatment on the catalytic performance of CeO2 for CO oxidation. Molecular Catalysis. 528. 112465–112465. 13 indexed citations

14.

Kirste, Simon, Alexander Rühle, Stefan Zschiedrich, et al.. (2022). Stereotactic Body Radiotherapy for Renal Cell Carcinoma in Patients with Von Hippel–Lindau Disease—Results of a Prospective Trial. Cancers. 14(20). 5069–5069. 9 indexed citations

15.

Guo, Xiaofeng, Yan Liu, Emily Kim, et al.. (2019). Effect of cyclical intermittent hypoxia on Ad5CMVCre induced solitary lung cancer progression and spontaneous metastases in the KrasG12D+; p53fl/fl; myristolated p110fl/fl ROSA-gfp mouse. PLoS ONE. 14(2). e0212930–e0212930. 15 indexed citations

16.

Tjalma, Wiebren, et al.. (2017). The impact on women’s health and the cervical cancer screening budget of primary HPV screening with dual-stain cytology triage in Belgium. European Journal of Obstetrics & Gynecology and Reproductive Biology. 212. 171–181. 21 indexed citations

17.

Lim, Diane C, Emily Kim, Brendan T Keenan, et al.. (2016). Different cyclical intermittent hypoxia severities have different effects on hippocampal microvasculature. Journal of Applied Physiology. 121(1). 78–88. 17 indexed citations

18.

Lim, Diane C, Li‐Pang Chuang, Emily Kim, et al.. (2014). Simulating obstructive sleep apnea patients' oxygenation characteristics into a mouse model of cyclical intermittent hypoxia. Journal of Applied Physiology. 118(5). 544–557. 35 indexed citations

19.

Tzimenatos, Leah, Emily Kim, & Nathan Kuppermann. (2014). The Pediatric Emergency Care Applied Research Network. Pediatric Emergency Care. 31(1). 70–76. 14 indexed citations

20.

Kim, Emily, et al.. (2001). Certified Macromedia Coldfusion 5: Developer Study Guide. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact